ID   LIPA4_HUMAN             Reviewed;        1185 AA.
AC   O75335; A2RUJ5; B1APN8; B1N949; B7ZM43; O94971;
DT   16-FEB-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-FEB-2014, sequence version 3.
DT   28-JUN-2023, entry version 166.
DE   RecName: Full=Liprin-alpha-4;
DE   AltName: Full=Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-4;
DE            Short=PTPRF-interacting protein alpha-4;
GN   Name=PPFIA4; Synonyms=KIAA0897;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Spangler S.A., Hoogenraad C.C.;
RT   "Characterization of liprins in the central nervous system.";
RL   Submitted (FEB-2007) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 626-1134 (ISOFORM 2), AND TISSUE SPECIFICITY.
RC   TISSUE=Brain, Fetal brain, Heart, and Kidney;
RX   PubMed=9624153; DOI=10.1074/jbc.273.25.15611;
RA   Serra-Pages C., Medley Q.G., Tang M., Hart A., Streuli M.;
RT   "Liprins, a family of LAR transmembrane protein-tyrosine phosphatase-
RT   interacting proteins.";
RL   J. Biol. Chem. 273:15611-15620(1998).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 767-1185 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [7]
RP   IDENTIFICATION.
RX   PubMed=14612982;
RA   Katoh M., Katoh M.;
RT   "Identification and characterization of human PPFIA4 gene in silico.";
RL   Int. J. Mol. Med. 12:1009-1014(2003).
CC   -!- FUNCTION: May regulate the disassembly of focal adhesions. May localize
CC       receptor-like tyrosine phosphatases type 2A at specific sites on the
CC       plasma membrane, possibly regulating their interaction with the
CC       extracellular environment and their association with substrates (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Forms homodimers and heterodimers with liprins-alpha and
CC       liprins-beta. Interacts with the second PTPase domain of PTPRD, PTPRF
CC       and PTPRS. Interacts with RIMS1 and RIMS2 (By similarity). Interacts
CC       with GIT1 and GIT2 (By similarity). Interacts with GRIP1 (By
CC       similarity). Interacts with KIF1A (By similarity).
CC       {ECO:0000250|UniProtKB:Q91Z80}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Cell surface
CC       {ECO:0000250}. Note=Colocalizes with PTPRF at the cell surface.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=3;
CC         IsoId=O75335-3; Sequence=Displayed;
CC       Name=1;
CC         IsoId=O75335-1; Sequence=VSP_053668, VSP_053669;
CC       Name=2;
CC         IsoId=O75335-2; Sequence=VSP_053668, VSP_053669, VSP_053670;
CC   -!- TISSUE SPECIFICITY: Expressed only in the heart, brain, and skeletal
CC       muscle. {ECO:0000269|PubMed:9624153}.
CC   -!- DOMAIN: The N-terminal coiled coil regions mediate homodimerization
CC       preferentially and heterodimerization type alpha/alpha. The C-terminal,
CC       non-coiled coil regions mediate heterodimerization type alpha/beta and
CC       interaction with PTPRD, PTPRF and PTPRS (By similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the liprin family. Liprin-alpha subfamily.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF428334; ABR09268.1; -; mRNA.
DR   EMBL; AK126624; BAC86617.1; -; mRNA.
DR   EMBL; AC096632; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC105940; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451082; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC132923; AAI32924.1; -; mRNA.
DR   EMBL; BC132925; AAI32926.1; -; mRNA.
DR   EMBL; BC144262; AAI44263.1; -; mRNA.
DR   EMBL; AF034801; AAC26102.1; -; mRNA.
DR   EMBL; AB020704; BAA74920.1; -; mRNA.
DR   RefSeq; NP_001291260.1; NM_001304331.1.
DR   RefSeq; NP_001291261.1; NM_001304332.1.
DR   AlphaFoldDB; O75335; -.
DR   SMR; O75335; -.
DR   BioGRID; 114069; 7.
DR   IntAct; O75335; 4.
DR   STRING; 9606.ENSP00000272198; -.
DR   GlyCosmos; O75335; 1 site, 1 glycan.
DR   GlyGen; O75335; 1 site, 1 O-linked glycan (1 site).
DR   iPTMnet; O75335; -.
DR   PhosphoSitePlus; O75335; -.
DR   BioMuta; PPFIA4; -.
DR   EPD; O75335; -.
DR   jPOST; O75335; -.
DR   MassIVE; O75335; -.
DR   MaxQB; O75335; -.
DR   PeptideAtlas; O75335; -.
DR   ProteomicsDB; 3392; -.
DR   ProteomicsDB; 49906; -. [O75335-3]
DR   ProteomicsDB; 49907; -. [O75335-2]
DR   Antibodypedia; 34537; 45 antibodies from 17 providers.
DR   DNASU; 8497; -.
DR   Ensembl; ENST00000272198.10; ENSP00000272198.6; ENSG00000143847.16. [O75335-1]
DR   Ensembl; ENST00000447715.6; ENSP00000402576.1; ENSG00000143847.16. [O75335-3]
DR   Ensembl; ENST00000599966.5; ENSP00000471264.1; ENSG00000143847.16. [O75335-2]
DR   GeneID; 8497; -.
DR   KEGG; hsa:8497; -.
DR   UCSC; uc001gyz.3; human. [O75335-3]
DR   AGR; HGNC:9248; -.
DR   CTD; 8497; -.
DR   DisGeNET; 8497; -.
DR   GeneCards; PPFIA4; -.
DR   HGNC; HGNC:9248; PPFIA4.
DR   HPA; ENSG00000143847; Tissue enhanced (brain, heart muscle, skeletal muscle).
DR   MIM; 603145; gene.
DR   neXtProt; NX_O75335; -.
DR   OpenTargets; ENSG00000143847; -.
DR   PharmGKB; PA33569; -.
DR   VEuPathDB; HostDB:ENSG00000143847; -.
DR   eggNOG; KOG0249; Eukaryota.
DR   GeneTree; ENSGT01050000244900; -.
DR   HOGENOM; CLU_006923_2_0_1; -.
DR   InParanoid; O75335; -.
DR   OrthoDB; 2906732at2759; -.
DR   TreeFam; TF314207; -.
DR   PathwayCommons; O75335; -.
DR   Reactome; R-HSA-181429; Serotonin Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-181430; Norepinephrine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-210500; Glutamate Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-212676; Dopamine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-264642; Acetylcholine Neurotransmitter Release Cycle.
DR   Reactome; R-HSA-388844; Receptor-type tyrosine-protein phosphatases.
DR   SignaLink; O75335; -.
DR   BioGRID-ORCS; 8497; 22 hits in 1157 CRISPR screens.
DR   ChiTaRS; PPFIA4; human.
DR   GeneWiki; PPFIA4; -.
DR   GenomeRNAi; 8497; -.
DR   Pharos; O75335; Tbio.
DR   PRO; PR:O75335; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O75335; protein.
DR   Bgee; ENSG00000143847; Expressed in cerebellar hemisphere and 128 other tissues.
DR   ExpressionAtlas; O75335; baseline and differential.
DR   Genevisible; O75335; HS.
DR   GO; GO:0009986; C:cell surface; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0048786; C:presynaptic active zone; IBA:GO_Central.
DR   GO; GO:0045202; C:synapse; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0050808; P:synapse organization; IBA:GO_Central.
DR   CDD; cd09562; SAM_liprin-alpha1_2_3_4_repeat1; 1.
DR   CDD; cd09565; SAM_liprin-alpha1_2_3_4_repeat2; 1.
DR   CDD; cd09568; SAM_liprin-alpha1_2_3_4_repeat3; 1.
DR   Gene3D; 1.10.150.50; Transcription Factor, Ets-1; 3.
DR   InterPro; IPR029515; Liprin.
DR   InterPro; IPR037620; Liprin-alpha_SAM_rpt_1.
DR   InterPro; IPR037621; Liprin-alpha_SAM_rpt_2.
DR   InterPro; IPR037622; Liprin-alpha_SAM_rpt_3.
DR   InterPro; IPR001660; SAM.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12587; LAR INTERACTING PROTEIN LIP -RELATED PROTEIN; 1.
DR   PANTHER; PTHR12587:SF5; LIPRIN-ALPHA-4; 1.
DR   Pfam; PF00536; SAM_1; 2.
DR   Pfam; PF07647; SAM_2; 1.
DR   SMART; SM00454; SAM; 3.
DR   SUPFAM; SSF47769; SAM/Pointed domain; 3.
DR   PROSITE; PS50105; SAM_DOMAIN; 3.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Coiled coil; Cytoplasm; Phosphoprotein;
KW   Reference proteome; Repeat.
FT   CHAIN           1..1185
FT                   /note="Liprin-alpha-4"
FT                   /id="PRO_0000191032"
FT   DOMAIN          829..895
FT                   /note="SAM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          944..1008
FT                   /note="SAM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   DOMAIN          1032..1101
FT                   /note="SAM 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00184"
FT   REGION          638..709
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          721..757
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          24..123
FT                   /evidence="ECO:0000255"
FT   COILED          165..499
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        638..655
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        668..696
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        725..743
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         640
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z80"
FT   MOD_RES         681
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q91Z80"
FT   VAR_SEQ         1..510
FT                   /note="Missing (in isoform 1 and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10048485,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9624153"
FT                   /id="VSP_053668"
FT   VAR_SEQ         545..588
FT                   /note="LALPLTVTLRSPTWMRMSQGVCCNLEYHSSGTLCGSSGPLPVPE -> DWET
FT                   SPLPGMLAPAAGPAFDSDPEISDVDEDEPGGLVGSADVVSPSGHSDAQTLAMMLQEQLD
FT                   AINEEIR (in isoform 1 and isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10048485,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9624153"
FT                   /id="VSP_053669"
FT   VAR_SEQ         928..936
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9624153"
FT                   /id="VSP_053670"
FT   CONFLICT        803
FT                   /note="A -> S (in Ref. 3; AAI44263)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1134
FT                   /note="G -> A (in Ref. 5; AAC26102)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1185 AA;  134404 MW;  0DD1431820D2313E CRC64;
     MCEVMPTINE GDRLGPPHGA DADANFEQLM VNMLDEREKL LESLRESQET LAATQSRLQD
     AIHERDQLQR HLNSALPQEF ATLTRELSMC REQLLEREEE ISELKAERNN TRLLLEHLEC
     LVSRHERSLR MTVVKRQAQS PSGVSSEVEV LKALKSLFEH HKALDEKVRE RLRAALERVT
     TLEEQLAGAH QQVSALQQGA GVRDGAAEEE GTVELGPKRL WKEDTGRVEE LQELLEKQNF
     ELSQARERLV TLTTTVTELE EDLGTARRDL IKSEELSSKH QRDLREALAQ KEDMEERITT
     LEKRYLAAQR EATSIHDLND KLENELANKE SLHRQCEEKA RHLQELLEVA EQKLQQTMRK
     AETLPEVEAE LAQRIAALTK AEERHGNIEE HLRQLEGQLE EKNQELARTA VQVRQREKMN
     EDHNKRLSDT VDRLLSESNE RLQLHLKERM AALEEKNTLI QELESSQRQI EEQHHHKGRL
     SEEIEKLRQE VDQLKGRGGP FVDGVHSRSH MGSAADVRFS LGTTTHAPPG VHRRYSALRE
     ESAKLALPLT VTLRSPTWMR MSQGVCCNLE YHSSGTLCGS SGPLPVPEMI QEEKESTELR
     AEEIETRVTS GSMEALNLKQ LRKRGSIPTS LTALSLASAS PPLSGRSTPK LTSRSAAQDL
     DRMGVMTLPS DLRKHRRKLL SPVSREENRE DKATIKCETS PPSSPRTLRL EKLGHPALSQ
     EEGKSALEDQ GSNPSSSNSS QDSLHKGAKR KGIKSSIGRL FGKKEKGRLI QLSRDGATGH
     VLLTDSEFSM QEPMVPAKLG TQAEKDRRLK KKHQLLEDAR RKGMPFAQWD GPTVVSWLEL
     WVGMPAWYVA ACRANVKSGA IMSALSDTEI QREIGISNAL HRLKLRLAIQ EMVSLTSPSA
     PPTSRTSSGN VWVTHEEMET LETSTKTDSE EGSWAQTLAY GDMNHEWIGN EWLPSLGLPQ
     YRSYFMECLV DARMLDHLTK KDLRVHLKMV DSFHRTSLQY GIMCLKRLNY DRKELEKRRE
     ESQHEIKDVL VWTNDQVVHW VQSIGLRDYA GNLHESGVHG ALLALDENFD HNTLALILQI
     PTQNTQARQV MEREFNNLLA LGTDRKLDDG DDKVFRRAPS WRKRFRPREH HGRGGMLSAS
     AETLPAGFRV STLGTLQPPP APPKKIMPEA HSHYLYGHML SAFRD
//
